| Role of neurochemicals in the interaction between the microbiota and the immune and the nervous system of the host organism AV Oleskin, BA Shenderov, VS Rogovsky Probiotics and Antimicrobial Proteins 9, 215-234, 2017 | 81 | 2017 |
| Antiproliferative and antioxidant activity of new dihydroquercetin derivatives VS Rogovskiĭ, AI Matiushin, NL Shimanovskiĭ, AV Semeĭkin, ... Eksperimental'naia i klinicheskaia farmakologiia 73 (9), 39-42, 2010 | 63 | 2010 |
| The linkage between inflammation and immune tolerance: interfering with inflammation in cancer V Stanislavovich Rogovskii Current cancer drug targets 17 (4), 325-332, 2017 | 50 | 2017 |
| Dopaminergic therapeutics in multiple sclerosis: focus on Th17-cell functions M Melnikov, V Rogovskii, A Boykо, M Pashenkov Journal of Neuroimmune Pharmacology 15, 37-47, 2020 | 35 | 2020 |
| Immune tolerance as the physiologic counterpart of chronic inflammation V Rogovskii Frontiers in Immunology 11, 2061, 2020 | 34 | 2020 |
| The influence of glatiramer acetate on Th17-immune response in multiple sclerosis M Melnikov, S Sharanova, A Sviridova, V Rogovskii, N Murugina, ... PLoS One 15 (10), e0240305, 2020 | 27 | 2020 |
| The possibility of preventive and therapeutic use of green tea catechins in prostate cancer VS Rogovskii, SV Popov, NV Sturov, NL Shimanovskii Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 23 | 2019 |
| The influence of biogenic amines on Th17-mediated immune response in multiple sclerosis M Melnikov, V Rogovskii, A Boyko, M Pashenkov Multiple sclerosis and related disorders 21, 19-23, 2018 | 21 | 2018 |
| Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy. M Melnikov, A Sviridova, V Rogovskii, A Oleskin, M Boziki, C Bakirtzis, ... Multiple Sclerosis and Related Disorders 51, 102888, 2021 | 19 | 2021 |
| The therapeutic potential of urolithin A for cancer treatment and prevention VS Rogovskii Current cancer drug targets 22 (9), 717-724, 2022 | 18 | 2022 |
| Modulation of inflammation-induced tolerance in cancer V Rogovskii Frontiers in Immunology 11, 1180, 2020 | 18 | 2020 |
| The role of 5-HT2B-receptors in fluoxetine-mediated modulation of Th17-and Th1-cells in multiple sclerosis A Sviridova, V Rogovskii, V Kudrin, M Pashenkov, A Boyko, M Melnikov Journal of Neuroimmunology 356, 577608, 2021 | 12 | 2021 |
| The Dual Role of the β2-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple Sclerosis M Melnikov, V Rogovskii, A Sviridova, A Lopatina, M Pashenkov, A Boyko International Journal of Molecular Sciences 23 (2), 668, 2022 | 10 | 2022 |
| Antihypertensive and neuroprotective activity of quercetin and its derivatives VS Rogovskiĭ, NL Shimanovskiĭ, AI Matiushin Eksperimental'naia i Klinicheskaia Farmakologiia 75 (9), 37-41, 2012 | 9 | 2012 |
| Polyphenols as the potential disease-modifying therapy in cancer V Rogovskii Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents) 22 (13), 2385-2392, 2022 | 8 | 2022 |
| Synthesis and antioxidant and cytotoxic activity of new dihydroquercetin derivatives VV Knyazev, VS Rogovskii, ED Sveshnikova, AV Semeikin, AI Matyushin, ... Pharmaceutical Chemistry Journal 52, 205-208, 2018 | 8 | 2018 |
| Role of biogenic amines in the interaction between the microbiota and the nervous and the immune system of the host organism AV Oleskin, VS Rogovskii Bulletin of Rehabilitation Medicine 77 (1), 41-51, 2017 | 7 | 2017 |
| The influence of fluoxetine on interleukin-6 and interleukin-1β production by dendritic cells in multiple sclerosis in vitro LV Krivenko, AA Sviridova, MV Melnikov, VS Rogovskii, AN Boyko, ... Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 120 (7. Vyp. 2), 67-72, 2020 | 6 | 2020 |
| Sotsial’nost’mikroorganizmov i vzaimootnosheniya v sisteme mikrobiota-khozyain: rol'neiromediatorov (Sociality of Microorganisms and Relationships in the Microbiota-Host System … AV Oleskin, BA Shenderov, VS Rogovskii Gos. Univ, 2020 | 5 | 2020 |
| The role of D2-like dopaminergic receptor in dopamine-mediated modulation of Th17-cells in multiple sclerosis M Melnikov, A Sviridova, V Rogovskii, V Kudrin, V Murugin, A Boyko, ... Current Neuropharmacology 20 (8), 1632, 2022 | 4 | 2022 |
